Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel.
Date: November 28-29, 2001.
Time: 9 am to 5 pm.
Agenda: To review and evaluate grant applications.
Place: Marriott Suites, 6711 Democracy Blvd., Bethesda, MD 20814.
Contact Person: Linda W. Engel, M.S., Special Assistant to the Director, National Center for Complementary and Alternative Medicine, 6707 Democracy Blvd., Suite 200, MSC 5475, Bethesda, MD 20892, (301) 496-1944, firstname.lastname@example.org.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.Start Signature
Dated: November 16, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-29536 Filed 11-27-01; 8:45 am]
BILLING CODE 4140-01-M